Trezix
- Product NDC
- 66992-840
- 11-digit product format
- 669920840
- Labeler code
- 66992
- Product ID
- 66992-840_34095d36-7525-4953-bce7-d86031545d5a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acetaminophen, caffeine, dihydrocodeine bitartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Wraser Llc
- Application
- ANDA204785
- Marketing category
- ANDA
- Marketing start
- 2014-12-01
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
- Active strength
- 321 mg/1; mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 66992-840-10 | Trezix | 100 in 1 BOTTLE | CAPSULE | 100 | | 12 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| DIHYDROCODEINE BITARTRATE | ACTIVE INGREDIENT | 8LXS95BSA9 | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| DIHYDROCODEINE | ACTIVE MOIETY | N9I9HDB855 | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66992-840 | TREZIX (ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE) CAPSULE [WRASER LLC] | 12 | Legacy NDC, 1 package rows | 20210204_a519a201-bcfd-4029-9bdf-fc3e03f975ac.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66992-840-10 | 66992084010 | 100 CAPSULE in 1 BOTTLE (66992-840-10) | 100 capsule | 2014-12-01 | 0000-00-00 | No | No | Current |